JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5876
VanEck Green Bond ETF
GRNB
$191M
| $9K | ﹤0.01% |
+375
| New | +$8.74K |
2023 Q1
0 quarters
|
|
|
GRVY
5877
GRAVITY
GRVY
$474M
| $9K | ﹤0.01% |
157
+57
| +57% | +$2.9K |
2021 Q2
7 quarters
|
|
5878
Mistras Group
MG
$654M
| $9K | ﹤0.01% |
1,326
+1,173
| +767% | +$6.42K |
2017 Q4
21 quarters
|
|
5879
Omeros
OMER
$1.37B
| $9K | ﹤0.01% |
1,911
+168
| +10% | +$606 |
2017 Q4
21 quarters
|
|
5880
PrimeEnergy Resources
PNRG
$332M
| $9K | ﹤0.01% |
112
-100
| -47% | -$8.89K |
2021 Q4
5 quarters
|
|
5881
Invesco S&P SmallCap Energy ETF
PSCE
$107M
| $9K | ﹤0.01% |
203
| – | – |
2022 Q4
1 quarter
|
|
5882
VirnetX Holding Corp
VHC
$46.6M
| $9K | ﹤0.01% |
330
+143
| +76% | +$4.63K |
2017 Q4
21 quarters
|
|
5883
ProShares VIX Mid-Term Futures ETF
VIXM
$50.4M
| $9K | ﹤0.01% |
329
+27
| +9% | +$721 |
2018 Q4
17 quarters
|
|
5884
Xilio Therapeutics
XLO
$60.1M
| $9K | ﹤0.01% |
193
| – | – |
2021 Q4
5 quarters
|
|
|
AUMN
5885
DELISTED
Golden Minerals Company
AUMN
| $9K | ﹤0.01% |
1,851
+1,251
| +209% | +$7.96K |
2013 Q2
39 quarters
|
|
|
MMAT
5886
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $9K | ﹤0.01% |
210
+113
| +116% | +$8.78K |
2021 Q2
7 quarters
|
|
|
CYXT
5887
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $9K | ﹤0.01% |
28,464
+7,324
| +35% | +$15.5K |
2021 Q4
5 quarters
|
|
|
BOAC.WS
5888
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
| – | – |
0
| – | – |
2022 Q1
4 quarters
|
|
5889
T. Rowe Price US Equity Research ETF
TSPA
$4.67B
| $8.84K | ﹤0.01% |
+360
| New | +$8.57K |
2023 Q1
0 quarters
|
|
5890
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$155M
| $8.69K | ﹤0.01% |
+384
| New | +$8.66K |
2023 Q1
0 quarters
|
|
5891
Dimensional Global Real Estate ETF
DFGR
$3.63B
| $8.59K | ﹤0.01% |
+350
| New | +$8.84K |
2023 Q1
0 quarters
|
|
5892
Capital Group International Focus Equity ETF
CGXU
$7.02B
| $8.37K | ﹤0.01% |
+361
| New | +$8.07K |
2023 Q1
0 quarters
|
|
5893
VanEck CEF Muni Income ETF
XMPT
$196M
| $8.06K | ﹤0.01% |
+372
| New | +$8.09K |
2023 Q1
0 quarters
|
|
|
CMPS
5894
Compass Pathways
CMPS
$1.59B
| $8K | ﹤0.01% |
789
-1,977
| -71% | -$18.2K |
2021 Q2
7 quarters
|
|
|
DMO
5895
Western Asset Mortgage Opportunity Fund
DMO
$107M
| $8K | ﹤0.01% |
+738
| New | +$8.1K |
2023 Q1
0 quarters
|
|
5896
Global X E-commerce ETF
EBIZ
$24.8M
| $8K | ﹤0.01% |
+469
| New | +$8.63K |
2023 Q1
0 quarters
|
|
5897
Evolution Petroleum
EPM
$144M
| $8K | ﹤0.01% |
1,214
+1,060
| +688% | +$6.79K |
2017 Q3
22 quarters
|
|
5898
Escalade
ESCA
$263M
| $8K | ﹤0.01% |
579
| – | – |
2017 Q4
21 quarters
|
|
5899
PUT
Exelon
EXC
$42.1B
| $8K | ﹤0.01% |
200
-192,500
| -100% | -$8.02M |
2021 Q1
8 quarters
|
|
5900
Fortress Biotech
FBIO
$70.7M
| $8K | ﹤0.01% |
674
| – | – |
2019 Q3
14 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.